Rheumatoid Arthritis

 

Direct Costs to Patients for RA Treatment: $12,509-$36,053

November 20, 2020

The annual direct costs for rheumatoid arthritis (RA) patients are estimated to range from $12,509-$36,053. A late diagnosis costs even more and one in 10 new RA cases are usually diagnosed late. In this presentation, Kathryn Johnson, RPh, of CVS Health breaks down the numbers.

Fluctuating Weight in RA Can Heighten CVD Risk

November 04, 2020

Weight fluctuation in rheumatoid arthritis patients appears to be associated with higher cardiovascular risk in patients with rheumatoid arthritis, especially if they are not overweight, shows a new study.

Exercise Types Essential in Rheumatic Disease

October 31, 2020

Patients with inflammatory arthritis and osteoarthritis should be participating in four different types of exercise: cardiovascular, strength, flexibility, and balance. But a new study shows that patients are overly focused on cardiovascular exercise and not enough on exercise types designed to strengthen and protect joints and bones. In this interview, Dr. Lauren Freid, a rheumatologist with the University of California Los Angeles and the lead investigator of a study on physical activity in people with inflammatory arthritis and osteoarthritis, addresses exercise essentials for inflammatory rheumatic disease.

Rheumatoid Arthritis With PTSD, Anxiety and Depression

October 16, 2020

Stress and anxiety can wreak havoc on one's health and hinder recovery, particularly for patients with chronic conditions, such as rheumatoid arthritis. In an article published online Sept. 13 in ACR Open Rheumatology, Joshua F. Baker, M.D., and colleagues report the results of study that finds veterans with rheumatoid arthritis and comorbid PTSD, depression, or anxiety, have poor persistence of methotrexate and TNFi therapies leading to worse outcomes. He addresses the study findings in this interview.

Rheumatoid Arthritis As Two Diseases

October 12, 2020

The underlying pathogenesis of rheumatoid arthritis with and without autoantibodies may be different. Researchers say that "it is time to formally subdivide RA into type 1 (with autoantibodies) and type 2 (without autoantibodies)."

One-on-one With Dr. Dimitrios Pappas: Etanercept as Monotherapy in RA

October 09, 2020

In today’s one-on-one interview, we talk with Dimitrios A. Pappas, M.D., MPH, scientific director of the Corrona RA Registry and an adjunct professor with Columbia University. He and his team recently published results from the registry in ACR Open Rheumatology which show that rheumatoid arthritis patients may be able to maintain remission or low disease activity with etanercept (Enbrel, Amgen) monotherapy long-term treatment.